214 related articles for article (PubMed ID: 17194504)
1. Role of NPY for vasoregulation in the splanchnic circulation during portal hypertension.
Wiest R; Jurzik L; Herold T; Straub RH; Schölmerich J
Peptides; 2007 Feb; 28(2):396-404. PubMed ID: 17194504
[TBL] [Abstract][Full Text] [Related]
2. Enhanced Y1-receptor-mediated vasoconstrictive action of neuropeptide Y (NPY) in superior mesenteric arteries in portal hypertension.
Wiest R; Jurzik L; Moleda L; Froh M; Schnabl B; von Hörsten S; Schölmerich J; Straub RH
J Hepatol; 2006 Mar; 44(3):512-9. PubMed ID: 16324766
[TBL] [Abstract][Full Text] [Related]
3. Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.
Moleda L; Trebicka J; Dietrich P; Gäbele E; Hellerbrand C; Straub RH; Sauerbruch T; Schoelmerich J; Wiest R
Gut; 2011 Aug; 60(8):1122-32. PubMed ID: 21317421
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y restores non-receptor-mediated vasoconstrictive action in superior mesenteric arteries in portal hypertension.
Hartl J; Dietrich P; Moleda L; Müller-Schilling M; Wiest R
Liver Int; 2015 Dec; 35(12):2556-63. PubMed ID: 26010514
[TBL] [Abstract][Full Text] [Related]
5. Dysbalance in sympathetic neurotransmitter release and action in cirrhotic rats: impact of exogenous neuropeptide Y.
Dietrich P; Moleda L; Kees F; Müller M; Straub RH; Hellerbrand C; Wiest R
J Hepatol; 2013 Feb; 58(2):254-61. PubMed ID: 23041305
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of nNOS and associated increase in nitrergic vasodilation in superior mesenteric arteries in pre-hepatic portal hypertension.
Jurzik L; Froh M; Straub RH; Schölmerich J; Wiest R
J Hepatol; 2005 Aug; 43(2):258-65. PubMed ID: 15963596
[TBL] [Abstract][Full Text] [Related]
7. Alterations in mechanical properties of mesenteric resistance arteries in experimental portal hypertension.
Resch M; Wiest R; Moleda L; Fredersdorf S; Stoelcker B; Schroeder JA; Schölmerich J; Endemann DH
Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G849-57. PubMed ID: 19696142
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of portal hypertension.
Bosch J; Pizcueta P; Feu F; Fernández M; García-Pagán JC
Gastroenterol Clin North Am; 1992 Mar; 21(1):1-14. PubMed ID: 1568769
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of genes related to the adrenergic system may contribute to splanchnic vasodilation in rat portal hypertension.
Coll M; Genescà J; Raurell I; Rodríguez-Vilarrupla A; Mejías M; Otero T; Oria M; Esteban R; Guardia J; Bosch J; Martell M
J Hepatol; 2008 Jul; 49(1):43-51. PubMed ID: 18457899
[TBL] [Abstract][Full Text] [Related]
10. Atrophy of mesenteric sympathetic innervation may contribute to splanchnic vasodilation in rat portal hypertension.
Coll M; Martell M; Raurell I; Ezkurdia N; Cuenca S; Hernández-Losa J; Esteban R; Guardia J; Bosch J; Genescà J
Liver Int; 2010 Apr; 30(4):593-602. PubMed ID: 19968782
[TBL] [Abstract][Full Text] [Related]
11. Restriction of drinking water abrogates splanchnic vasodilation and portal hypertension in portal vein-ligated rats.
Heinemann A; Schuligoi R; Lippe IT; Stauber RE
Pharmacology; 2009; 83(1):26-32. PubMed ID: 18987488
[TBL] [Abstract][Full Text] [Related]
12. [Circulatory dysfunction syndrome associated with liver cirrhosis].
Hartleb M
Przegl Epidemiol; 2005; 59(2):549-58. PubMed ID: 16190566
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic changes in splanchnic blood vessels in portal hypertension.
Colle I; Geerts AM; Van Steenkiste C; Van Vlierberghe H
Anat Rec (Hoboken); 2008 Jun; 291(6):699-713. PubMed ID: 18484617
[TBL] [Abstract][Full Text] [Related]
14. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.
Xu J; Cao H; Liu H; Wu ZY
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.
Fernandez M; Mejias M; Angermayr B; Garcia-Pagan JC; Rodés J; Bosch J
J Hepatol; 2005 Jul; 43(1):98-103. PubMed ID: 15893841
[TBL] [Abstract][Full Text] [Related]
16. Vascular deterioration in cirrhosis: the big picture.
Bosch J
J Clin Gastroenterol; 2007; 41 Suppl 3():S247-53. PubMed ID: 17975472
[TBL] [Abstract][Full Text] [Related]
17. Increased heme oxygenase activity in splanchnic organs from portal hypertensive rats: role in modulating mesenteric vascular reactivity.
Fernandez M; Lambrecht RW; Bonkovsky HL
J Hepatol; 2001 Jun; 34(6):812-7. PubMed ID: 11451163
[TBL] [Abstract][Full Text] [Related]
18. Molecular Mechanisms Leading to Splanchnic Vasodilation in Liver Cirrhosis.
Di Pascoli M; Sacerdoti D; Pontisso P; Angeli P; Bolognesi M
J Vasc Res; 2017; 54(2):92-99. PubMed ID: 28402977
[TBL] [Abstract][Full Text] [Related]
19. The molecules: mechanisms of arterial vasodilatation observed in the splanchnic and systemic circulation in portal hypertension.
Iwakiri Y
J Clin Gastroenterol; 2007; 41 Suppl 3():S288-94. PubMed ID: 17975478
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of extrahepatic vasodilation in portal hypertension.
Hennenberg M; Trebicka J; Sauerbruch T; Heller J
Gut; 2008 Sep; 57(9):1300-14. PubMed ID: 18445644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
